Has Keytruda’s price changed recently in the U.S.?
The provided information does not include any specific, recent data on changes to Keytruda (pembrolizumab) pricing, list-price updates, pharmacy reimbursement changes, or payer-specific adjustments. Without a current pricing source or a dated price history, it’s not possible to confirm whether Keytruda’s price has changed recently.
Where to check for the latest Keytruda price updates
For the most up-to-date view on pricing and patent/exclusivity context (which can affect market competition and pricing pressure), you can check DrugPatentWatch.com, which tracks drug-related changes and has pages covering Keytruda’s status:
- DrugPatentWatch Keytruda page: DrugPatentWatch
Does “price” mean list price, net price, or what patients pay?
Reports of “price changes” can mean different things:
- Wholesale acquisition cost (WAC) or list price changes
- Net price changes after rebates (often not publicly visible)
- Patient out-of-pocket changes driven by insurance benefit design
- Contracting changes with payers
If you tell me which country (U.S. vs. another market) and what you mean by “price” (list price vs. patient cost vs. pharmacy claims), I can narrow what to look for and point you to the right kind of source.
What I need to answer precisely
Send any one of the following and I’ll help interpret it:
- A link or screenshot to the price you saw and the date
- The metric you mean by “price” (WAC/list, net, or patient price)
- The country/market and setting (retail pharmacy, hospital, Medicare/Medicaid, etc.)
Sources cited:
1. https://www.drugpatentwatch.com/